Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial

MLA

Batra, Gorav, et al. “Effects of Early Myocardial Reperfusion and Perfusion on Myocardial Necrosis/Dysfunction and Inflammation in Patients with ST-Segment and Non-ST-Segment Elevation Acute Coronary Syndrome: Results from the PLATelet Inhibition and Patients Outcomes (PLATO) Trial.” European Heart Journal Acute Cardiovascular Care, vol. 11, no. 4, Apr. 2022, pp. 336–49. EBSCOhost, https://doi.org/10.1093/ehjacc/zuac020.

APA

Batra, G., Renlund, H., Kunadian, V., James, S. K., Storey, R. F., Steg, P. G., Katus, H. A., Harrington, R. A., Gibson, C. M., Budaj, A., Siegbahn, A., & Wallentin, L. (2022). Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial. European Heart Journal Acute Cardiovascular Care, 11(4), 336–349. https://doi.org/10.1093/ehjacc/zuac020

Chicago

Batra, Gorav, Henrik Renlund, Vijay Kunadian, Stefan K James, Robert F Storey, P Gabriel Steg, Hugo A Katus, et al. 2022. “Effects of Early Myocardial Reperfusion and Perfusion on Myocardial Necrosis/Dysfunction and Inflammation in Patients with ST-Segment and Non-ST-Segment Elevation Acute Coronary Syndrome: Results from the PLATelet Inhibition and Patients Outcomes (PLATO) Trial.” European Heart Journal Acute Cardiovascular Care 11 (4): 336–49. doi:10.1093/ehjacc/zuac020.